ART-TG accelerator of technological innovation in gene therapy

Enabling innovation in cell and gene therapy

In the news

ART-TG : Laureate EIC for TREM2MEDS

We are thrilled to announce that ART-TG will be showcased by Inserm (the French National Institute of Health and Medical Research) for its participation in the groundbreaking European Innovation Council (EIC) research project TREM2MEDS . The project will be presented on March 13th, 2026 (9h00-14h00) at the Paris Santé Campus 2-10 rue d'Ouradour-sur-glane Paris 75015. ART-TG participates as a partner within the TREM2MEDS consortium led by Prof. Alessandra Biffi from UNIPD (U

Best wishes for 2026 !

#BonneAnnée2026 #MeilleursVœux #ARTTG

Expertise

dna-g624eb8017_1920 gerd altmann pixabay.jpg

Translational research in cell and gene therapy

Lentiviral vector production

About us

ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

Anne Galy, founder of ART-TG (view her bio)

SEE MORE INFORMATION

Our projects are funded by

ART-TG is accessible by public transportation: about 400m from RER-D Bras de Fer-Genepole station